Bioretec Appoints New Chief Executive Officer
Bioretec Ltd., known for its innovative approaches in the field of absorbable orthopedic implants, has taken an exciting step forward by appointing Sarah van Hellenberg Hubar-Fisher as the company's new Chief Executive Officer (CEO). This pivotal decision is aimed at bolstering the company's expansion plans and enhancing their impact in the medical technology landscape.
Leadership Transition
Having served as the interim CEO since earlier in the year and as a board member since 2021, van Hellenberg Hubar-Fisher is no stranger to the inner workings of Bioretec. Under her interim leadership, the company has made notable advancements, including key regulatory achievements that have set the stage for future growth.
The board of directors also announced that Antti Vasara has been elected as the new Vice Chairman, stepping into the role to support the company's strategic initiatives moving forward. This transition reflects a solid commitment to strong governance and company vision.
Vision for Bioretec’s Future
Sarah van Hellenberg Hubar-Fisher is poised to drive Bioretec's mission forward. "I am thrilled to lead Bioretec into its next phase of growth as we continue to introduce groundbreaking orthopedic technologies to the market," she expressed. She emphasized the company’s goals to accelerate the global rollout of their RemeOs™ system, while also building on the success of their Activa® product line.
In her vision, van Hellenberg Hubar-Fisher aims to ensure that both platforms are backed by the necessary resources and processes for scaling, reinforcing Bioretec's positioning in the industry. With RemeOs now equipped with CE marking and Activa enjoying ongoing market success, the future appears promising for the company.
Expertise and Experience
With over 23 years of experienced leadership in healthcare and medical technology, van Hellenberg Hubar-Fisher brings a wealth of knowledge to her new role. She has a proven ability to translate innovative ideas into tangible results in the healthcare sector. In addition to her leadership role at Bioretec, she is also involved with Global Surgical Initiatives, Inc., which supports surgical care in underserved communities.
Her impressive resume includes senior roles at industry leaders such as Johnson & Johnson and participation in venture capital at Nina Capital and Growth Science Ventures. Her academic achievements, including an MBA from Babson College and a postgraduate degree from the University of Oxford, further enhance her qualifications as a leader in this dynamic field.
Bioretec’s Innovative Approach
Bioretec has established itself as a frontrunner in medical technology, particularly known for its unique biodegradable implant solutions. Their range includes Activa®, a bioabsorbable orthopedic implant crafted from a proprietary PLGA polymer, which safely degrades over time, greatly reducing the need for secondary surgeries.
The company’s latest advancement, RemeOs™, represents a new generation of absorbable implants made from a high-performance magnesium alloy composite, designed to elevate surgical outcomes. The recent authorizations for these innovative products show Bioretec’s commitment to enhancing patient care through technology.
As Bioretec continues to reshape orthopedic treatment, it is on the path to becoming a global market leader in absorbable orthopedic implants, striving for a significant clinical impact and long-term value for its shareholders.
Frequently Asked Questions
Who is the new CEO of Bioretec?
Sarah van Hellenberg Hubar-Fisher has been appointed as the new CEO of Bioretec, effective immediately.
What experience does Sarah van Hellenberg Hubar-Fisher have?
She brings over 23 years of leadership experience in healthcare and medical technology, with a strong track record in launching innovative technologies.
What are Bioretec's primary products?
Bioretec specializes in absorbable orthopedic implants, including the Activa® and RemeOs™ product lines, designed to foster bone growth and facilitate healing.
What are Bioretec's goals under the new leadership?
The company aims to expand its commercial footprint and enhance the global launch of its orthopedic technologies.
In how many countries are Bioretec's products used?
Products developed by Bioretec are utilized in approximately 40 countries worldwide, showcasing their global reach and impact.
